Literature DB >> 11468963

Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.

M McMorran, D Vu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11468963

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

2.  Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts.

Authors:  Huamei He; Hai Tao; Hui Xiong; Sheng Zhong Duan; Francis X McGowan; Richard M Mortensen; James A Balschi
Journal:  Toxicol Sci       Date:  2014-01-21       Impact factor: 4.849

3.  Developmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheep.

Authors:  Almudena Veiga-Lopez; James S Lee; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2010-06-16       Impact factor: 4.736

Review 4.  Combined thiazolidinedione-insulin therapy: should we be concerned about safety?

Authors:  André J Scheen
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.